We are excited to announce that Dr. Zanos, the Director of the Translational Neuropharmacology Laboratory, has been honored with the prestigious 2025 Research Excellence Award from the University of Cyprus. The award, presented by the Minister of Education of Cyprus on June 25, 2025, recognizes Dr. Zanos’ and our lab’s groundbreaking contributions to neuroscience and the transformative impact on research infrastructure in Cyprus.

Dr. Zanos’ pioneering work focuses on the discovery of novel rapid-acting antidepressants, with significant findings published in top-tier journals such as Nature, PNAS, Nature Neuroscience, e.t.c.. His research has led to a successful Phase I clinical trial for a new antidepressant compound in collaboration with the National Institute of Mental Health (USA), with Phase II trials now underway to evaluate its efficacy for severe depression. Additionally, Dr. Zanos is leading three innovative clinical trials in Cyprus, including the nation’s first interventional drug trial to prevent opioid relapse and studies exploring the neurobiological mechanisms of nicotine addiction and smoking cessation.

Despite being an early-career investigator, he has published over 75 articles in high-impact journals, secured patents in multiple countries, and obtained over €2.2 million in competitive funding during his first 4 years of independent position. 

This award highlights Dr. Zanos’ commitment to translating cutting-edge research into real-world clinical applications, elevating Cyprus’ standing in the global scientific community.

We extend our congratulations to Dr. Zanos and the entire lab team for their dedication to advancing neuroscience through innovative research.